Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- BAF1338 - Provider product page
- Provider
- Novus Biologicals
- Product name
- Goat Polyclonal alpha-Synuclein Antibody
- Antibody type
- Polyclonal
- Description
- Antigen Affinity-purified. Detects human alpha-Synuclein in Western blots.
- Reactivity
- Human
- Host
- Goat
- Conjugate
- Biotin
- Isotype
- IgG
- Vial size
- 50 ug
- Concentration
- LYOPH
- Storage
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Submitted references Visual hallucinations in Alzheimer's disease do not seem to be associated with chronic hypoperfusion of to visual processing areas V2 and V3 but may be associated with reduced cholinergic input to these areas.
Transmission of α-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson's disease?
Endothelin-converting enzymes degrade α-synuclein and are reduced in dementia with Lewy bodies.
Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson's disease patients.
Using gastrocnemius sEMG and plasma α-synuclein for the prediction of freezing of gait in Parkinson's disease patients.
DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease.
Sinclair LI, Kumar A, Darreh-Shori T, Love S
Alzheimer's research & therapy 2019 Sep 12;11(1):80
Alzheimer's research & therapy 2019 Sep 12;11(1):80
Transmission of α-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson's disease?
Matsumoto J, Stewart T, Sheng L, Li N, Bullock K, Song N, Shi M, Banks WA, Zhang J
Acta neuropathologica communications 2017 Sep 13;5(1):71
Acta neuropathologica communications 2017 Sep 13;5(1):71
Endothelin-converting enzymes degrade α-synuclein and are reduced in dementia with Lewy bodies.
Miners JS, Love S
Journal of neurochemistry 2017 Apr;141(2):275-286
Journal of neurochemistry 2017 Apr;141(2):275-286
Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson's disease patients.
Kang W, Chen W, Yang Q, Zhang L, Zhang L, Wang X, Dong F, Zhao Y, Chen S, Quinn TJ, Zhang J, Chen S, Liu J
Scientific reports 2016 Jun 23;6:28143
Scientific reports 2016 Jun 23;6:28143
Using gastrocnemius sEMG and plasma α-synuclein for the prediction of freezing of gait in Parkinson's disease patients.
Wang XY, Kang WY, Yang Q, Zhang LY, Chen SD, Liu J
PloS one 2014;9(2):e89353
PloS one 2014;9(2):e89353
DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease.
Hong Z, Shi M, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Leverenz JB, Baird G, Montine TJ, Hancock AM, Hwang H, Pan C, Bradner J, Kang UJ, Jensen PH, Zhang J
Brain : a journal of neurology 2010 Mar;133(Pt 3):713-26
Brain : a journal of neurology 2010 Mar;133(Pt 3):713-26
No comments: Submit comment
No validations: Submit validation data